204 related articles for article (PubMed ID: 35742955)
1. Genomic Analysis Made It Possible to Identify Gene-Driver Alterations Covering the Time Window between Diagnosis of Neuroblastoma 4S and the Progression to Stage 4.
Ognibene M; De Marco P; Parodi S; Meli M; Di Cataldo A; Zara F; Pezzolo A
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742955
[TBL] [Abstract][Full Text] [Related]
2. Integrated CGH/WES Analyses Advance Understanding of Aggressive Neuroblastoma Evolution: A Case Study.
Corallo D; Zanon C; Pantile M; Tonini GP; Zin A; Francescato S; Rossi B; Trevisson E; Pinato C; Monferrer E; Noguera R; Aliño SF; Herrero MJ; Biffi A; Viscardi E; Aveic S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685674
[TBL] [Abstract][Full Text] [Related]
3. Genomic coamplification of CDK4/MDM2/FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients.
Amoroso L; Ognibene M; Morini M; Conte M; Di Cataldo A; Tondo A; D'Angelo P; Castellano A; Garaventa A; Lasorsa VA; Podestà M; Capasso M; Pezzolo A
Genes Chromosomes Cancer; 2020 May; 59(5):277-285. PubMed ID: 31756773
[TBL] [Abstract][Full Text] [Related]
4. Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma.
Altun Z; Yuan H; Baran B; Aktaş S; Sönmez EE; Küçük C; Olgun N
Gene; 2023 Apr; 860():147233. PubMed ID: 36736507
[TBL] [Abstract][Full Text] [Related]
5. MYCN-non-amplified metastatic neuroblastoma with good prognosis and spontaneous regression: a molecular portrait of stage 4S.
Bénard J; Raguénez G; Kauffmann A; Valent A; Ripoche H; Joulin V; Job B; Danglot G; Cantais S; Robert T; Terrier-Lacombe MJ; Chassevent A; Koscielny S; Fischer M; Berthold F; Lipinski M; Tursz T; Dessen P; Lazar V; Valteau-Couanet D
Mol Oncol; 2008 Oct; 2(3):261-71. PubMed ID: 19383347
[TBL] [Abstract][Full Text] [Related]
6. cDNA array-CGH profiling identifies genomic alterations specific to stage and MYCN-amplification in neuroblastoma.
Chen QR; Bilke S; Wei JS; Whiteford CC; Cenacchi N; Krasnoselsky AL; Greer BT; Son CG; Westermann F; Berthold F; Schwab M; Catchpoole D; Khan J
BMC Genomics; 2004 Sep; 5():70. PubMed ID: 15380028
[TBL] [Abstract][Full Text] [Related]
7. Multiple Genes with Potential Tumor Suppressive Activity Are Present on Chromosome 10q Loss in Neuroblastoma and Are Associated with Poor Prognosis.
Ognibene M; De Marco P; Amoroso L; Cangelosi D; Zara F; Parodi S; Pezzolo A
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046696
[TBL] [Abstract][Full Text] [Related]
8. Copy number variants calling from WES data through eXome hidden Markov model (XHMM) identifies additional 2.5% pathogenic genomic imbalances smaller than 30 kb undetected by array-CGH.
Tisserant E; Vitobello A; Callegarin D; Verdez S; Bruel AL; Aho Glele LS; Sorlin A; Viora-Dupont E; Konyukh M; Marle N; Nambot S; Moutton S; Racine C; Garde A; Delanne J; Tran-Mau-Them F; Philippe C; Kuentz P; Poulleau M; Payet M; Poe C; Thauvin-Robinet C; Faivre L; Mosca-Boidron AL; Thevenon J; Duffourd Y; Callier P
Ann Hum Genet; 2022 Jul; 86(4):171-180. PubMed ID: 35141892
[TBL] [Abstract][Full Text] [Related]
9. Genome instability model of metastatic neuroblastoma tumorigenesis by a dictionary learning algorithm.
Masecchia S; Coco S; Barla A; Verri A; Tonini GP
BMC Med Genomics; 2015 Sep; 8():57. PubMed ID: 26358114
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.
Li S; Mi T; Jin L; Liu Y; Zhang Z; Wang J; Wu X; Ren C; Wang Z; Kong X; Liu J; Luo J; He D
J Cancer Res Clin Oncol; 2024 Mar; 150(3):148. PubMed ID: 38512513
[TBL] [Abstract][Full Text] [Related]
11. Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma.
Chen QR; Bilke S; Wei JS; Greer BT; Steinberg SM; Westermann F; Schwab M; Khan J
Genes Chromosomes Cancer; 2006 Sep; 45(9):856-62. PubMed ID: 16804916
[TBL] [Abstract][Full Text] [Related]
12. High-resolution cDNA microarray-based comparative genomic hybridization analysis in neuroblastoma.
Chen QR; Bilke S; Khan J
Cancer Lett; 2005 Oct; 228(1-2):71-81. PubMed ID: 15951107
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastoma.
Coco S; Theissen J; Scaruffi P; Stigliani S; Moretti S; Oberthuer A; Valdora F; Fischer M; Gallo F; Hero B; Bonassi S; Berthold F; Tonini GP
Int J Cancer; 2012 Oct; 131(7):1591-600. PubMed ID: 22234802
[TBL] [Abstract][Full Text] [Related]
14. Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and CIC in neuroblastoma.
Fransson S; Östensson M; Djos A; Javanmardi N; Kogner P; Martinsson T
Int J Oncol; 2016 Mar; 48(3):1103-16. PubMed ID: 26794043
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of potential driver genes with genomic alterations predicts survival of high-risk neuroblastoma patients.
Suo C; Deng W; Vu TN; Li M; Shi L; Pawitan Y
Biol Direct; 2018 Jul; 13(1):14. PubMed ID: 30012197
[TBL] [Abstract][Full Text] [Related]
16. High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.
Romania P; Castellano A; Surace C; Citti A; De Ioris MA; Sirleto P; De Mariano M; Longo L; Boldrini R; Angioni A; Locatelli F; Fruci D
PLoS One; 2013; 8(10):e78481. PubMed ID: 24205241
[TBL] [Abstract][Full Text] [Related]
17. Loss of whole chromosome X predicts prognosis of neuroblastoma patients with numerical genomic profile.
Parodi S; Pistorio A; Erminio G; Ognibene M; Morini M; Garaventa A; Gigliotti AR; Haupt R; Frassoni F; Pezzolo A
Pediatr Blood Cancer; 2019 May; 66(5):e27635. PubMed ID: 30688024
[TBL] [Abstract][Full Text] [Related]
18. [Genomic profile in high risk neuroblastoma by comparative genomic hybridization].
Noguera Salvá R; Piqueras Franco M; Ruiz Saurí A; Llombart-Bosch A; Castel Sánchez V; Navarro Fos S
An Pediatr (Barc); 2006 May; 64(5):449-56. PubMed ID: 16756886
[TBL] [Abstract][Full Text] [Related]
19. Inferring a tumor progression model for neuroblastoma from genomic data.
Bilke S; Chen QR; Westerman F; Schwab M; Catchpoole D; Khan J
J Clin Oncol; 2005 Oct; 23(29):7322-31. PubMed ID: 16145061
[TBL] [Abstract][Full Text] [Related]
20. Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.
Bellini A; Bessoltane-Bentahar N; Bhalshankar J; Clement N; Raynal V; Baulande S; Bernard V; Danzon A; Chicard M; Colmet-Daage L; Pierron G; Le Roux L; Planchon JM; Combaret V; Lapouble E; Corradini N; Thebaud E; Gambart M; Valteau-Couanet D; Michon J; Louis-Brennetot C; Janoueix-Lerosey I; Defachelles AS; Bourdeaut F; Delattre O; Schleiermacher G
Int J Cancer; 2019 Nov; 145(10):2781-2791. PubMed ID: 31018240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]